Glucose control and vascular complications in veterans with type 2 diabetes

Cited by (1,057)

Items 401–500 of 1,057

1. Hypoglycemia, Diabetes, and Cardiovascular Disease
   Janet K. Snell‐Bergeon, Raj Paul Wadwa · 2012 · Diabetes Technology & Therapeutics
2. Assessing Potential Glycemic Overtreatment in Persons at Hypoglycemic Risk
   Chin‐Lin Tseng, Orysya Soroka, Miriam Maney, David Clark Aron, LEONARD M. POGACH · 2013 · JAMA Internal Medicine
3. Metabolic memory: mechanisms and diseases
   Hao Dong, Yuezhang Sun, Lulingxiao Nie, Aimin Cui, Pengfei Zhao, Wai Keung Leung, Qi Wang · 2024 · Signal Transduction and Targeted Therapy
4. Effect of Intensive Compared With Standard Glycemia Treatment Strategies on Mortality by Baseline Subgroup Characteristics
   Calles-Escandón, Jorge, Lovato, Laura C., Simons-Morton, Denise G., Kendall, David M., Pop-Busui, Rodica, Cohen, Robert M., Bonds, Denise E., Fonseca, Vivian A., Ismail-Beigi, Faramarz, Banerji, Mary Ann et al. · 2010 · Diabetes Care
5. Adverse effects and safety of SGLT-2 inhibitors
   S. Halimi, Bruno L Vergès · 2014 · Diabetes & Metabolism
6. Glycemic Control in Type 2 Diabetes: Time for an Evidence-Based About-Face?
   Víctor M. Montori, Mercè Fernández-Balsells · 2009 · Annals of Internal Medicine
7. Effects of β-blockers on glucose and lipid metabolism
   Vivian Andrew Fonseca · 2010 · Current Medical Research and Opinion
8. Ten Emerging Trends in the Epidemiology of Diabetic Retinopathy
   Charumathi Sabanayagam, Wanfen Yip, Daniel Shu Wei Ting, Gavin Siew Wei Tan, Tien Yin Wong · 2016 · Ophthalmic Epidemiology
9. Glucose-lowering drugs or strategies, atherosclerotic cardiovascular events, and heart failure in people with or at risk of type 2 diabetes: an updated systematic review and meta-analysis of randomised cardiovascular outcome trials
   Ghosh-Swaby, Olivia R, Goodman, Shaun G, Leiter, Lawrence A, Cheng, Alice, Connelly, Kim A, Fitchett, David, Jüni, Peter, Farkouh, Michael E, Udell, Jacob A · 2020 · The Lancet Diabetes & Endocrinology
10. Severe Hypoglycemia Predicts Mortality in Diabetes
    Philip E. Cryer · 2012 · Diabetes Care
11. Prestroke Glycemic Control Is Associated With the Functional Outcome in Acute Ischemic Stroke
    Masahiro Kamouchi, Takayuki Matsuki, Jun Hata, Takahiro Kuwashiro, Tetsuro Ago, Yoshiki Sambongi, Yoshihisa Fukushima, Hiroshi Sugimori, Takanari Kitazono, for the FSR Investigators · 2011 · Stroke
12. Pathophysiology of type 2 diabetes and its treatment policy
    浩平 加来 · 2009 · 日本医師会雑誌
13. Hypoglycemia in diabetes: An update on pathophysiology, treatment, and prevention
    Afif Nakhleh, Naim Shehadeh · 2021 · World Journal of Diabetes
14. Benefits and harms of intensive glycemic control in patients with type 2 diabetes
    Rodriguez-Gutierrez, René, Gonzalez-Gonzalez, José Gerardo, Zuñiga-Hernandez, Jorge A, McCoy, Rozalina G · 2019 · BMJ
15. Diabetic neuropathy
    Brian Christopher Callaghan, Junguk Hur, Eva L. Feldman · 2012 · Current Opinion in Neurology
16. Updates on the Management of Diabetes in Dialysis Patients
    Connie M. Rhee, Angela M. Leung, Csaba Pal Kovesdy, Katherine E. Lynch, Gregory A. Brent, Kamyar Kalantar‐Zadeh · 2014 · Seminars in Dialysis
17. Cardiac Autonomic Neuropathy in Diabetes: A Predictor of Cardiometabolic Events
    Aaron I. Vinik, CAROLINA M. CASELLINI, Henri K. Parson, Sheri R. Colberg, Marie-Laure Névoret · 2018 · Frontiers in Neuroscience
18. Evidence That Hyperglycemia After Recovery From Hypoglycemia Worsens Endothelial Function and Increases Oxidative Stress and Inflammation in Healthy Control Subjects and Subjects With Type 1 Diabetes
    Ceriello, Antonio, Novials, Anna, Ortega, Emilio, La Sala, Lucia, Pujadas, Gemma, Testa, Roberto, Bonfigli, Anna Rita, Esposito, Katherine, Giugliano, Dario · 2012 · Diabetes
19. Glycemic variability and cardiovascular disease in patients with type 2 diabetes
    Martinez, Marcela, Santamarina, Jimena, Pavesi, Adrian, Musso, Carla, Umpierrez, Guillermo E · 2021 · BMJ Open Diabetes Research & Care
20. Breaking down patient and physician barriers to optimize glycemic control in type 2 diabetes.
    S. Ross · 2013 · American Journal of Medicine
21. Effects of Aggressive Versus Moderate Glycemic Control on Clinical Outcomes in Diabetic Coronary Artery Bypass Graft Patients
    Harold L. Lazar, Marie Elizabeth McDonnell, Stuart R. Chipkin, Carmel A. Fitzgerald, Caleb A. Bliss, Howard Cabral · 2011 · Annals of Surgery
22. Diabetes and Arrhythmias: Pathophysiology, Mechanisms and Therapeutic Outcomes
    Laurel A. Grisanti · 2018 · Frontiers in Physiology
23. Diabetic kidney disease: An overview of prevalence, risk factors, and biomarkers
    Salman Hussain, Mohammad Chand Jamali, Anwar Habib, Md. Sarfaraj Hussain, Mohd Akhtar, Abul Kalam Najmi · 2020 · Clinical Epidemiology and Global Health
24. Effects of diabetes on myocardial infarct size and cardioprotection by preconditioning and postconditioning
    Takayuki Miki, Takahito Itoh, Daisuke Sunaga, Tetsuji Miura · 2012 · Cardiovascular Diabetology
25. Screening for, Monitoring, and Treatment of Chronic Kidney Disease Stages 1 to 3: A Systematic Review for the U.S. Preventive Services Task Force and for an American College of Physicians Clinical Practice Guideline
    Howard A Fink, Areef Ishani, Brent C. Taylor, Nancy L. Greer, Roderick MacDonald, Dominic Rossini, Sameea Sadiq, Srilakshmi Lankireddy, Robert L Kane, Timothy J. Wilt · 2012 · Annals of Internal Medicine
26. The duration of diabetes affects the response to intensive glucose control in type 2 subjects: the VA Diabetes Trial
    Duckworth, William C., Abraira, Carlos, Moritz, Thomas E., Davis, Stephen N., Emanuele, Nicholas, Goldman, Steven, Hayward, Rodney, Huang, Grant D., Marks, Jennifer B., Reaven, Peter D. et al. · 2011 · Journal of Diabetes and its Complications
27. Insulin Therapy for Type 2 Diabetes Mellitus
    Amisha Wallia, Mark E. Molitch · 2014 · JAMA
28. Cardiovascular safety of exenatide BID: an integrated analysis from controlled clinical trials in participants with type 2 diabetes
    Robert E. Ratner, Jenny Han, Dawn Nicewarner, Irina Yushmanova, Byron J. Hoogwerf, Larry Zaiqian Shen · 2011 · Cardiovascular Diabetology
29. Metabolic memory and diabetic nephropathy: potential role for epigenetic mechanisms
    Stephen J. Tonna, Assam El‐Osta, Mark Emmanuel Cooper, Chris Tikellis · 2010 · Nature Reviews Nephrology
30. The Effects of Dipeptidyl Peptidase-4 Inhibition on Microvascular Diabetes Complications
    Angelo Avogaro, Gian Paolo Fadini · 2014 · Diabetes Care
31. Cardiovascular Risk Factor Targets and Cardiovascular Disease Event Risk in Diabetes: A Pooling Project of the Atherosclerosis Risk in Communities Study, Multi-Ethnic Study of Atherosclerosis, and Jackson Heart Study
    Nathan D. Wong, Yanglu Zhao, Rohini J. Patel, Christopher Patao, Shaista Malik, Alain Gerald Bertoni, Adolfo Correa, Aaron R. Folsom, Sumesh Kachroo, Jayanti Mukherjee et al. · 2016 · Diabetes Care
32. Cardiovascular outcomes in type 1 and type 2 diabetes
    Annika Rosengren, Pigi Dikaiou · 2023 · Diabetologia
33. Guidelines and Recommendations for Laboratory Analysis in the Diagnosis and Management of Diabetes Mellitus
    David B. Sacks, Mark A. Arnold, George L. Bakris, David E. Bruns, Andrea Rita Horvath, Åke Lernmark, Boyd E. Metzger, David M. Nathan, Marian Sue Kirkman · 2023 · Clinical Chemistry
34. Intensified glucose lowering in type 2 diabetes: time for a reappraisal
    John S Yudkin, Bernd Richter, E. A. M. Gale · 2010 · Diabetologia
35. DEVOTE 3: temporal relationships between severe hypoglycaemia, cardiovascular outcomes and mortality
    on behalf of the DEVOTE Study Group, Thomas Rudolf Pieber, Steven P. Marso, Darren K. McGuire, Bernard Zinman, Neil R Poulter, Scott S. Emerson, Richard E. Pratley, Vincent C. Woo, Simon R. Heller et al. · 2017 · Diabetologia
36. Gaps and barriers in the control of blood glucose in people with type 2 diabetes
    Lawrence Blonde, Pablo J. Aschner, Clifford J. Bailey, Linong Ji, Lawrence A. Leiter, Stephan Matthaei, on behalf of the Global Partnership for Effective Diabetes Management · 2017 · Diabetes and Vascular Disease Research
37. Diagnosis and Treatment of Type 2 Diabetes in Adults
    Kalyani, Rita R., Neumiller, Joshua J., Maruthur, Nisa M., Wexler, Deborah J. · 2025 · JAMA
38. Corneal confocal microscopy detects improvement in corneal nerve morphology with an improvement in risk factors for diabetic neuropathy
    Mitra Tavakoli, Panagiotis A. Kallinikos, Abid Iqbal, Annie Herbert, Hassan Fadavi, Nathan Efron, A. J. M. Boulton, Rayaz Ahmed Malik · 2011 · Diabetic Medicine
39. Untitled work
    2023 · 10.1002/14651858.cd013775.pub2
40. Type 2 diabetes mellitus and heart failure, a scientific statement from the American Heart Association and Heart Failure Society of America
    Dunlay, Shannon M., Givertz, Michael M., Aguilar, David, Allen, Larry A., Chan, Michael, Desai, Akshay S., Deswal, Anita, Dickson, Victoria Vaughan, Kosiborod, Mikhail N., Lekavich, Carolyn L. et al. · 2019 · Journal of Cardiac Failure
41. Cardiovascular outcome trials in type 2 diabetes and the sulphonylurea controversy: Rationale for the active-comparator CAROLINA trial
    Julio Rosenstock, Nikolaus Marx, Steven E. Kahn, Bernard Zinman, John J.P. Kastelein, John M. Lachin, Erich Bluhmki, Sanjay Dhanji Patel, Odd-Erik Johansen, H.J. Woerle · 2013 · Diabetes and Vascular Disease Research
42. Cardiovascular Disease and Type 2 Diabetes: Has the Dawn of a New Era Arrived?
    Muhammad A. Abdul-Ghani, Ralph Anthony DeFronzo, Stefano Del Prato, ROBERT J. CHILTON, Rajvir Singh, Robert E. J. Ryder · 2017 · Diabetes Care
43. Management of hypoglycemia in older adults with type 2 diabetes
    Jeffrey S. Freeman · 2019 · Postgraduate Medicine
44. Thiazolidinedione Drugs and Cardiovascular Risks
    Sanjay Kaul, Ann F. Bolger, David M. Herrington, Robert Patrick Giugliano, Robert H. Eckel · 2010 · Journal of the American College of Cardiology
45. Renal and Cardiac Effects of DPP-4 Inhibitors – from Preclinical Development to Clinical Research
    Berthold Hocher, Christoph Reichetzeder, Markus Alter · 2012 · Kidney & Blood Pressure Research
46. Personalized Management of Hyperglycemia in Type 2 Diabetes
    Itamar Raz, Matthew C. Riddle, Julio Rosenstock, John B. Buse, Silvio E. Inzucchi, Philip Home, Stefano Del Prato, Ele Ferrannini, Juliana C.N. Chan, Lawrence A. Leiter et al. · 2013 · Diabetes Care
47. Intensive glycaemic control and cancer risk in type 2 diabetes: a meta-analysis of major trials
    Jeffrey A. Johnson, Samantha L. Bowker · 2010 · Diabetologia
48. The case for hypoglycaemia as a proarrhythmic event: basic and clinical evidence
    Charles Nordin · 2010 · Diabetologia
49. Once daily administration of the SGLT2 inhibitor, empagliflozin, attenuates markers of renal fibrosis without improving albuminuria in diabetic db/db mice
    Linda A. Gallo, Micheal S. Ward, Amelia K. Fotheringham, Aowen Zhuang, Danielle J. Borg, Nicole Flemming, Ben M. Harvie, Toni L. Kinneally, Shang-Ming Yeh, Domenica A. McCarthy et al. · 2016 · Scientific Reports
50. Type 2 diabetes and reduced exercise tolerance: a review of the literature through an integrated physiology approach
    Lorenzo Nesti, Nicola Riccardo Pugliese, Paolo Sciuto, Andrea Natali · 2020 · Cardiovascular Diabetology
51. Dapagliflozin exerts anti-inflammatory effects via inhibition of LPS-induced TLR-4 overexpression and NF-κB activation in human endothelial cells and differentiated macrophages
    Elaheh Abdollahi, Fariborz Keyhanfar, Ali‐Akbar Delbandi, Reza Falak, Seyed Javad Hajimiresmaiel, Massoumeh Shafiei · 2022 · European Journal of Pharmacology
52. Intensive treatment and severe hypoglycemia among adults with type 2 diabetes
    McCoy, Rozalina G., Lipska, Kasia J., Yao, Xiaoxi, Ross, Joseph S., Montori, Victor M., Shah, Nilay D. · 2016 · JAMA Internal Medicine
53. Management of diabetes mellitus in patients with chronic kidney disease
    Hahr, Allison J., Molitch, Mark E. · 2015 · Clinical Diabetes and Endocrinology
54. Visit-to-Visit HbA1c Variability Is Associated With Cardiovascular Disease and Microvascular Complications in Patients With Newly Diagnosed Type 2 Diabetes
    Sheyu Li, Imola Németh, Louise A. Donnelly, Simona M. Hapca, Kaixin Zhou, Ewan R. Pearson · 2019 · Diabetes Care
55. Chapter 3: Management of progression and complications of CKD
    2012 · Kidney International Supplements
56. Risk of Hypoglycemia in Older Veterans with Dementia and Cognitive Impairment: Implications for Practice and Policy
    Denise G. Feil, Mangala Rajan, Orysya Soroka, Chin‐Lin Tseng, Donald R. Miller, LEONARD M. POGACH · 2011 · Journal of the American Geriatrics Society
57. Death during intensive glycemic therapy of diabetes: mechanisms and implications
    Cryer, Philip E. · 2011 · The American Journal of Medicine
58. Effects of Bilio-Pancreatic Diversion on Diabetic Complications
    Amerigo Iaconelli, Simona Panunzi, Andrea De Gaetano, Melania Manco, Caterina Guidone, Laura Leccesi, Donatella Gniuli, G Nanni, Marco Castagneto, Giovanni Ghirlanda et al. · 2011 · Diabetes Care
59. Diabetic nephropathy
    Themis Zelmanovitz, Fernando Gerchman, Amely Ps Balthazar, Fúlvio Clemo Santos Thomazelli, Jorge Dias de Matos, Luís Henrique Santos Canani · 2009 · Diabetology & Metabolic Syndrome
60. Severe Hypoglycemia Requiring Medical Intervention in a Large Cohort of Adults With Diabetes Receiving Care in U.S. Integrated Health Care Delivery Systems: 2005–2011
    Pathak, Ram D., Schroeder, Emily B., Seaquist, Elizabeth R., Zeng, Chan, Lafata, Jennifer Elston, Thomas, Abraham, Desai, Jay, Waitzfelder, Beth, Nichols, Gregory A., Lawrence, Jean M. et al. · 2016 · Diabetes Care
61. Diabetic cardiomyopathy: prevalence, determinants and potential treatments
    Gaurav Singh Gulsin, Lavanya Athithan, Gerry Patrick McCann · 2019 · Therapeutic Advances in Endocrinology and Metabolism
62. The Impact of Liraglutide on Diabetes-Related Foot Ulceration and Associated Complications in Patients With Type 2 Diabetes at High Risk for Cardiovascular Events: Results From the LEADER Trial
    Dhatariya, Ketan, Bain, Stephen C., Buse, John B., Simpson, Richard, Tarnow, Lise, Kaltoft, Margit Staum, Stellfeld, Michael, Tornøe, Karen, Pratley, Richard E., the LEADER Publication Committee on behalf of the LEADER Trial Investigators · 2018 · Diabetes Care
63. Epigenetic Changes in Diabetes and Cardiovascular Risk
    Keating, Samuel T., Plutzky, Jorge, El-Osta, Assam · 2016 · Circulation Research
64. Individualised treatment targets for elderly patients with type 2 diabetes using vildagliptin add-on or lone therapy (INTERVAL): a 24 week, randomised, double-blind, placebo-controlled study
    William David Strain, Valentina Lukashevich, Wolfgang Kothny, Marie-José Hoellinger, Päivi Maria Paldánius · 2013 · The Lancet
65. Novel therapies with precision mechanisms for type 2 diabetes mellitus
    Leigh Perreault, Jay S. Skyler, Julio Rosenstock · 2021 · Nature Reviews Endocrinology
66. Vascular complications of diabetes: A narrative review
    Yongxia Lu, Wei Wang, Jingyu Liu, Min Xie, Qiang Liu, Sufang Li · 2023 · Medicine
67. Influenza Virus and Glycemic Variability in Diabetes: A Killer Combination?
    Katina D. Hulme, Linda A. Gallo, Kirsty Renfree Short · 2017 · Frontiers in Microbiology
68. Epigenetics in the pathogenesis of diabetic nephropathy
    Xue Li, Lihong Lu, Wenting Hou, Ting Huang, Xiangyuan Chen, Jie Qi, Yanjun Zhao, Minmin Zhu · 2021 · Acta Biochimica et Biophysica Sinica
69. Glucose variability in a 26-week randomized comparison of mealtime treatment with rapid-acting insulin versus GLP-1 agonist in participants with type 2 diabetes at high cardiovascular risk
    The FLAT-SUGAR Trial Investigators · 2016 · Diabetes Care
70. Insulin use and increased risk of mortality in type 2 diabetes: a cohort study
    John‐Michael Gamble, Scot H. Simpson, Dean T. Eurich, Sumit R. Majumdar, Jeffrey A. Johnson · 2009 · Diabetes Obesity and Metabolism
71. Sitagliptin Attenuates the Progression of Carotid Intima-Media Thickening in Insulin-Treated Patients With Type 2 Diabetes: The Sitagliptin Preventive Study of Intima-Media Thickness Evaluation (SPIKE)
    Tomoya Mita, Naoto Katakami, Toshihiko Shiraiwa, Hidenori Yoshii, Tomio Onuma, Nobuichi Kuribayashi, Takeshi Osonoi, Hideaki Kaneto, Keisuke Kosugi, Yutaka Umayahara et al. · 2016 · Diabetes Care
72. Management of patients with diabetes and CKD: conclusions from a “Kidney Disease: Improving Global Outcomes” (KDIGO) Controversies Conference
    Vlado Perkovic, Rajiv Agarwal, Paola Fioretto, Brenda R. Hemmelgarn, Adeera Levin, Merlin C. Thomas, Christoph Wanner, B.L. Kasiske, David Collins. Wheeler, Per‐Henrik Groop et al. · 2016 · Kidney International
73. Impact of Improved Glycemic Control on Cardiac Function in Type 2 Diabetes Mellitus
    Melissa Leung, Vincent Wai‐Sun Wong, Harold Malcolm Hudson, Dominic Y. Leung · 2016 · Circulation Cardiovascular Imaging
74. Screening for type 2 diabetes mellitus: a systematic review for the U.S. Preventive Services Task Force
    Selph, Shelley, Dana, Tracy, Blazina, Ian, Bougatsos, Christina, Patel, Hetal, Chou, Roger · 2015 · Annals of Internal Medicine
75. Advanced Glycation End Products, Oxidation Products, and Incident Cardiovascular Events in Patients With Type 2 Diabetes
    Koska, Juraj, Saremi, Aramesh, Howell, Scott, Bahn, Gideon, De Courten, Barbora, Ginsberg, Henry, Beisswenger, Paul J., Reaven, Peter D., for the VADT Investigators · 2018 · Diabetes Care
76. Global trend of diabetes mortality attributed to vascular complications, 2000–2016
    Wei Ling, Yi Huang, Yanmei Huang, Rongrong Fan, Yi Sui, Hai-Lu Zhao · 2020 · Cardiovascular Diabetology
77. Effects of Semaglutide on Heart Failure Outcomes in Diabetes and Chronic Kidney Disease in the FLOW Trial
    Pratley, Richard E., Tuttle, Katherine R., Rossing, Peter, Rasmussen, Søren, Perkovic, Vlado, Nielsen, Olav Wendelboe, Mann, Johannes F.E., MacIsaac, Richard J., Kosiborod, Mikhail N., Kamenov, Zdravko et al. · 2024 · Journal of the American College of Cardiology
78. Frequency and predictors of confirmed hypoglycaemia in type 1 and insulin-treated type 2 diabetes mellitus patients in a real-life setting: results from the DIALOG study
    Cariou, B., Fontaine, P., Eschwege, E., Lièvre, M., Gouet, D., Huet, D., Madani, S., Lavigne, S., Charbonnel, B. · 2015 · Diabetes & Metabolism
79. Epigenetic programming, early life nutrition and the risk of metabolic disease
    Block, Tomasz, El-Osta, Assam · 2017 · Atherosclerosis
80. Regression From Prediabetes to Normal Glucose Regulation Is Associated With Reduction in Cardiovascular Risk: Results From the Diabetes Prevention Program Outcomes Study
    Perreault, Leigh, Temprosa, Marinella, Mather, Kieren J., Horton, Ed, Kitabchi, Abbas, Larkin, Mary, Montez, Maria G., Thayer, Debra, Orchard, Trevor J., Hamman, Richard F. et al. · 2014 · Diabetes Care
81. Glycemic Variation and Cardiovascular Risk in the Veterans Affairs Diabetes Trial
    Zhou, Jin J., Schwenke, Dawn C., Bahn, Gideon, Reaven, Peter · 2018 · Diabetes Care
82. Targets for Glycemic Control
    S. Ali Imran, RÉMI P.R. RABASA-LHORET, Stuart A. Ross · 2013 · Canadian Journal of Diabetes
83. Megatrials in type 2 diabetes. From excitement to frustration?
    Stefano Del Prato · 2009 · Diabetologia
84. Historical HbA1c values may explain the type 2 diabetes legacy effect: UKPDS 88
    Lind, Marcus, Imberg, Henrik, Coleman, Ruth L., Nerman, Olle, Holman, Rury R. · 2021 · Diabetes Care
85. Effects of Randomization to Intensive Glucose Control on Adverse Events, Cardiovascular Disease, and Mortality in Older Versus Younger Adults in the ACCORD Trial
    Michael E. Miller, Jeff D. Williamson, Hertzel C. Gerstein, Robert P. Byington, William C. Cushman, Henry N. Ginsberg, Walter T. Ambrosius, Laura Lovato, William B. Applegate, for the ACCORD Investigators · 2013 · Diabetes Care
86. A systematic review and meta-analysis of glycemic control for the prevention of diabetic foot syndrome
    Rim Hasan, Belal Firwana, Tarig A. Elraiyah, Juan Pablo Domecq, Gabriela J. Prutsky, Mohammed Nabhan, Larry J. Prokop, Peter K. Henke, Απόστολος Τσάπας, Víctor M. Montori et al. · 2016 · Journal of Vascular Surgery
87. The molecular link between oxidative stress, insulin resistance, and type 2 diabetes: A target for new therapies against cardiovascular diseases
    Aikaterini Andreadi, Alfonso Bellia, Nicola Di Daniele, Marco Meloni, Renato Lauro, David Della‐Morte, Davide Lauro · 2021 · Current Opinion in Pharmacology
88. Exercise therapy in Type 2 diabetes
    Stephan Praet, Luc J. C. van Loon · 2009 · Acta Diabetologica
89. Diabetic autonomic neuropathy
    Aaron I. Vinik, Tomris A Erbas · 2013 · Handbook of clinical neurology
90. Clinical inertia is the enemy of therapeutic success in the management of diabetes and its complications: a narrative literature review
    Andreozzi, F., Candido, R., Corrao, S., Fornengo, R., Giancaterini, A., Ponzani, P., Ponziani, M. C., Tuccinardi, F., Mannino, D. · 2020 · Diabetology & Metabolic Syndrome
91. 6. Glycemic Goals, Hypoglycemia, and Hyperglycemic Crises: Standards of Care in Diabetes-2026.
    American Diabetes Association Professional Practice Committee for Diabetes*, Bajaj, Mandeep, McCoy, Rozalina G., Balapattabi, Kirthikaa, Bannuru, Raveendhara R., Bellini, Natalie J., Bennett, Allison K., Beverly, Elizabeth A., Briggs Early, Kathaleen, ChallaSivaKanaka, Sathyavathi et al. · 2026 · Diabetes Care
92. Recognition, Pathogenesis, and Treatment of Different Stages of Nephropathy in Patients With Type 2 Diabetes Mellitus
    George L. Bakris · 2011 · Mayo Clinic Proceedings
93. Is Glucose Control Important for Prevention of Cardiovascular Disease in Diabetes?
    Edoardo Mannucci, Ilaria Dicembrini, Angelo Lauria, Paolo Pozzilli · 2013 · Diabetes Care
94. Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Multiple Rising Doses of Empagliflozin in Patients with Type 2 Diabetes Mellitus
    Tim Heise, LEO J. SEMAN, Sreeraj Macha, Peter Jones, Alexandra Marquart, Sabine Pinnetti, Hans Juergen Woerle, Klaus A. Dugi · 2013 · Diabetes Therapy
95. Effects of Severe Hypoglycemia on Cardiovascular Outcomes and Death in the Veterans Affairs Diabetes Trial
    Stephen N. Davis, William C. Duckworth, Nicholas Emanuele, Rodney A. Hayward, Wyndy L. Wiitala, Lizy Thottapurathu, Domenic J. Reda, Peter D. Reaven · 2018 · Diabetes Care
96. Optimal insulin regimens in type 2 diabetes mellitus: systematic review and meta-analyses
    Daniel S Lasserson, Paul Glasziou, Rafael Perera, Rury R. Holman, Andrew A. Farmer · 2009 · Diabetologia
97. Five-Year Effectiveness of the Multidisciplinary Risk Assessment and Management Programme–Diabetes Mellitus (RAMP-DM) on Diabetes-Related Complications and Health Service Uses—A Population-Based and Propensity-Matched Cohort Study
    E. Wan, C. Fung, F. Jiao, E. Yu, Weng Y. Chin, D. Fong, C. Wong, A. K. L. Chan, K. H. Chan, R. Kwok et al. · 2017 · Diabetes Care
98. The metabolic syndrome and neuropathy: Therapeutic challenges and opportunities
    Brian Christopher Callaghan, Eva L. Feldman · 2013 · Annals of Neurology
99. Prandial inhaled insulin plus basal insulin glargine versus twice daily biaspart insulin for type 2 diabetes: a multicentre randomised trial
    Julio Rosenstock, Daniel L. Lorber, Luigi Gnudi, Campbell P. Howard, David W. Bilheimer, P.-C. Chang, Richard Petrucci, Anders Boss, Peter C. Richardson · 2010 · The Lancet
100. Diabetes and cancer I: risk, survival, and implications for screening
     Adedayo A. Onitilo, Jessica Marie Engel, Ingrid Glurich, Rachel V. Stankowski, Gail M. Williams, Suhail A.R. Doi · 2012 · Cancer Causes & Control